Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controls

Background: SARS-CoV-2 is spread primarily through droplets and aerosols. Exhaled aerosols are generated in the upper airways through shear stress and in the lung periphery by 'reopening of collapsed airways'. Aerosol measuring may detect highly contagious individuals ("super spreaders or super-emitters") and discriminate between SARS-CoV-2 infected and non-infected individuals. This is the first study comparing exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls.Design: A prospective observational cohort study in 288 adults, comprising 64 patients testing positive by SARS CoV-2 PCR before enrollment, and 224 healthy adults testing negative (matched control sample) at the Uni-versity Hospital Frankfurt, Germany, from February to June 2021. Study objective was to evaluate the con-centration of exhaled aerosols during physiologic breathing in SARS-CoV-2 PCR-positive and-negative subjects. Secondary outcome measures included correlation of aerosol concentration to SARS-CoV-2 PCR results, change in aerosol concentration due to confounders, and correlation between clinical symptoms and aerosol.Results: There was a highly significant difference in respiratory aerosol concentrations between SARS-CoV-2 PCR-positive (median 1490.5/L) and-negative subjects (median 252.0/L; p < 0.0001). There were no significant differences due to age, sex, smoking status, or body mass index. ROC analysis showed an AUC of 0.8918. Conclusions: Measurements of respiratory aerosols were significantly elevated in SARS-CoV-2 positive in-dividuals, which helps to understand the spread and course of respiratory viral infections, as well as the detection of highly infectious individuals.